Despite the success of this AP/T score in predicting the efficacy of anti-PD-L1 treatment, we consider that the AP/T score comprising the combination of the expression of XCR1 and CXCR3 ligands is one representative example and that this particular combination can be modified. This evidence concerns the gene XCR1 and alkaline phosphatase measurement.